Stine H Kresse

Summary

Affiliation: Institute for Cancer Research
Country: Norway

Publications

  1. pmc DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
    Stine H Kresse
    Department of Tumor Biology, Radiumhospitalet, Rikshospitalet, Oslo, Norway
    Mol Cancer 7:48. 2008
  2. pmc Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 7:e48262. 2012
  3. doi request reprint LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
    Stine H Kresse
    Department of Tumor Biology, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Genes Chromosomes Cancer 48:679-93. 2009
  4. pmc Modulation of the osteosarcoma expression phenotype by microRNAs
    Heidi M Namløs
    The EuroBoNet Network of Excellence on Bone Tumours, Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 7:e48086. 2012
  5. ncbi request reprint Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas
    Leonardo A Meza-Zepeda
    Department of Tumor Biology, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Cancer Res 66:8984-93. 2006
  6. pmc Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo, Norway
    Mol Cancer 4:39. 2005
  7. pmc DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 5:e15378. 2010
  8. doi request reprint Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
    Hege O Ohnstad
    Department of Tumor Biology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
    Cancer 119:1013-22. 2013
  9. doi request reprint Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
    Stine H Kresse
    Department of Tumor Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Cancer 118:558-70. 2012
  10. pmc Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    BMC Res Notes 3:223. 2010

Collaborators

Detail Information

Publications11

  1. pmc DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
    Stine H Kresse
    Department of Tumor Biology, Radiumhospitalet, Rikshospitalet, Oslo, Norway
    Mol Cancer 7:48. 2008
    ....
  2. pmc Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 7:e48262. 2012
    ..We have integrated genome-wide genetic and epigenetic profiles from the EuroBoNeT panel of 19 human osteosarcoma cell lines based on microarray technologies...
  3. doi request reprint LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
    Stine H Kresse
    Department of Tumor Biology, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Genes Chromosomes Cancer 48:679-93. 2009
    ..4-p15.3 and low expression of LSAMP (both P = 0.011) were significantly associated with poor survival. Our results show that LSAMP is a novel candidate tumor suppressor gene in osteosarcomas...
  4. pmc Modulation of the osteosarcoma expression phenotype by microRNAs
    Heidi M Namløs
    The EuroBoNet Network of Excellence on Bone Tumours, Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 7:e48086. 2012
    ..In order to investigate the involvement of miRNAs in osteosarcoma development, global microarray analyses of a panel of 19 human osteosarcoma cell lines was performed...
  5. ncbi request reprint Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas
    Leonardo A Meza-Zepeda
    Department of Tumor Biology, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Cancer Res 66:8984-93. 2006
    ..Our results show the potential of using array comparative genomic hybridization to classify histologically similar tumors such as GISTs and leiomyosarcomas...
  6. pmc Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo, Norway
    Mol Cancer 4:39. 2005
    ..In this study we have mapped and characterized the amplicon in 1q23 in more detail...
  7. pmc DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 5:e15378. 2010
    ....
  8. doi request reprint Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
    Hege O Ohnstad
    Department of Tumor Biology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
    Cancer 119:1013-22. 2013
    ..Relatively few sarcomas harbor TP53 (tumor protein p53) mutations, but in many cases, amplification of MDM2 (murine double minute 2) effectively inactivate p53. The p53 pathway activity can also be affected by normal genetic variation...
  9. doi request reprint Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
    Stine H Kresse
    Department of Tumor Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Cancer 118:558-70. 2012
    ..Human tumors transplanted into immunodeficient mice (xenografts) are good preclinical models, and it is important to identify possible systematic changes during establishment and passaging in mice...
  10. pmc Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
    Stine H Kresse
    Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    BMC Res Notes 3:223. 2010
    ..eu), we have evaluated four different commercial high-resolution microarray platforms in order to identify the most appropriate technology for mapping DNA copy number aberrations in such tumours...
  11. pmc M-CGH: analysing microarray-based CGH experiments
    Junbai Wang
    Department of Tumor Biology, The Norwegian Radium Hospital, Montebello, N 0310 Oslo, Norway
    BMC Bioinformatics 5:74. 2004
    ..Dedicated tools are needed to analyse the results of such experiments, which include appropriate visualisation, and to take into consideration the physical relation in the genome between the probes on the array...